524502 RAAJMEDI

Raaj Medisafe India Share Price

₹88.50 -0.75 (-0.84%)

23 Dec, 2024 08:28

SIP TrendupStart SIP in RAAJMEDI

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month + 2.9%
  • Over 3 Month -19.66%
  • Over 6 Month -13.24%
  • Over 1 Year + 139.45%
SIP Lightning

Smart Investing Starts Here Start SIP with Raaj Medisafe India for Steady Growth!

Invest Now

Raaj Medisafe India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Raaj Medisafe India Financials

Raaj Medisafe India Technicals

EMA & SMA

Current Price
₹88.50
-0.75 (-0.84%)
pointer
  • stock-down_img
  • Bullish Moving Average 6
  • stock-up_img
  • Bearish Moving Average 10
  • 20 Day
  • ₹90.00
  • 50 Day
  • ₹92.94
  • 100 Day
  • ₹89.57
  • 200 Day
  • ₹78.06

Resistance and Support

88.33 Pivot Speed
  • R3 89.17
  • R2 88.83
  • R1 88.67
  • S1 88.17
  • S2 87.83
  • S3 87.67

What's your outlook on Raaj Medisafe India?

You can only vote for once

Raaj Medisafe India Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-12 Quarterly Results
2024-08-14 Quarterly Results
2024-05-29 Audited Results
2024-05-06 Preferential issue of shares
2024-02-09 Quarterly Results

Raaj Medisafe India F&O

Raaj Medisafe India Shareholding Pattern

No data available.

About Raaj Medisafe India

  • NSE Symbol
  • RAAJMEDI
  • BSE Symbol
  • 524502
  • ISIN
  • INE548H01015

Similar Stocks to Raaj Medisafe India

Raaj Medisafe India FAQs

Raaj Medisafe India share price is ₹88 As on 23 December, 2024 | 08:14

The Market Cap of Raaj Medisafe India is ₹116.9 Cr As on 23 December, 2024 | 08:14

The P/E ratio of Raaj Medisafe India is 35.8 As on 23 December, 2024 | 08:14

The PB ratio of Raaj Medisafe India is 10.8 As on 23 December, 2024 | 08:14

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23